155 related articles for article (PubMed ID: 10454936)
21. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of idiopathic thrombopenic purpura in adolescents by intravenous immunoglobulin].
Rodríguez Cuartero A; González Martínez F
An Med Interna; 1998 Dec; 15(12):675-6. PubMed ID: 9972611
[No Abstract] [Full Text] [Related]
23. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
Kjaersgaard M; Hasle H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):717-20. PubMed ID: 16933265
[TBL] [Abstract][Full Text] [Related]
24. Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura.
Zunich KM; Harkonen WS; Woloski M; Kingsbury L
Lancet; 1995 Nov; 346(8986):1363-5. PubMed ID: 7475792
[No Abstract] [Full Text] [Related]
25. [The indications for intravenous immunoglobulins in pediatric practice].
Popescu V; Bleahu D
Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724
[TBL] [Abstract][Full Text] [Related]
26. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
Vermeulen M
Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
[No Abstract] [Full Text] [Related]
27. High dose intravenous immunoglobulin repertoire versus anti-D. Disproportions in quantity and quality.
Rewald E; Francischetti MM; Barberis L
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):265-9. PubMed ID: 12030430
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
[TBL] [Abstract][Full Text] [Related]
29. Intravenous IgG for treatment of autoimmune disease.
Schenkein DP
Hosp Pract (Off Ed); 1992 Oct; 27(10A):29-36, 39-42 45 passim. PubMed ID: 1400680
[No Abstract] [Full Text] [Related]
30. A therapy-refractory neonatal auto-immune thrombocytopenia treated with anti-D.
Gaedicke G; Cremer M; Meyer O; Salama A
Eur J Pediatr; 2004 Mar; 163(3):183-4. PubMed ID: 14691720
[No Abstract] [Full Text] [Related]
31. Anti-D for the treatment of splenectomized patients with immune thrombocytopenic purpura.
Cardo LJ; Strack M; Williams J
Blood; 1991 Nov; 78(10):2786-7. PubMed ID: 1668611
[No Abstract] [Full Text] [Related]
32. Fetal and neonatal cytopenias: what have we learned?
Bussel JB
Am J Perinatol; 2003 Nov; 20(8):425-31. PubMed ID: 14703590
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune (idiopathic) thrombocytopenic purpura.
Hauser S
Lancet; 1997 Aug; 350(9074):368. PubMed ID: 9251663
[No Abstract] [Full Text] [Related]
34. Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy.
Adams JR; Nathan DP; Bennett CL
Blood Rev; 2002 Mar; 16(1):65-7. PubMed ID: 11913999
[TBL] [Abstract][Full Text] [Related]
35. [The current studies of the treatment of idiopathic thrombocytopenic purpura].
Wang SH
Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):181-3. PubMed ID: 1327675
[No Abstract] [Full Text] [Related]
36. Optimal response to 100 microg/kg anti-Rh(D) in two patients who had suboptimal responses to 75 microg/kg anti-Rh(D).
Varma M; Beautyman EJ; Grossbard ML
Am J Hematol; 2009 Feb; 84(2):124. PubMed ID: 19051329
[No Abstract] [Full Text] [Related]
37. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
Buchanan GR; Journeycake JM; Adix L
Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
[TBL] [Abstract][Full Text] [Related]
38. [Immune thrombocytopenic purpura: pathophysiology and treatment].
Godeau B
Transfus Clin Biol; 2009 May; 16(2):101-5. PubMed ID: 19409827
[TBL] [Abstract][Full Text] [Related]
39. Treatment modalities of autoimmune blood disorders.
Collins PW; Newland AC
Semin Hematol; 1992 Jan; 29(1):64-74. PubMed ID: 1570545
[No Abstract] [Full Text] [Related]
40. Protective mechanisms of IVIG.
Clynes R
Curr Opin Immunol; 2007 Dec; 19(6):646-51. PubMed ID: 18032008
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
